Fondation D.E.V.E.N.I.R. - Page Zone Médicale Bibliothèque

Corporate Zone - Medical

Virtual scientific library

It is possible to obtain, free of charge, scientific articles or documents regarding products developed by corporate partner, with or without clinical indications included in the current monographs, as well as other information of interest for the nephrology community

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Tanaka T, et al. Clin Exp Nephrol 2019;23(2):231-43 There is no abstract available for this article.

Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.

Winkelmayer WC, et al. Am J Kidney Dis 2015;66 (1):106-13 There is no abstract available for this article.

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.

Vanrenterghem Y, et al. Kidney Int 2002;62(2):167-75 There is no abstract available for this article.